New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease

Contributed by: Business Wire

Logo

Tags

Software

General Health

Radiology

Pharmaceutical

Medical Devices

Technology

Healthcare Reform

Other Manufacturing

Manufacturing

Health

Diabetes

Public Policy/Government

Medical Technology

More Like This

New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease

A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol (Photo: Business Wire)

Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study

PR Newswire associated0

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

PR Newswire associated0

Echosens Launches its Liver Health Management (LHM) Platform Globally, Streamlining Liver Care

PR Newswire associated0

FibroScan® by Echosens Recognized in AASLD Practice Guidance on Managing Portal Hypertension and Varices in Cirrhosis

PR Newswire associated0

TRANSFORMING LIVER HEALTH: ECHOSENS NEXT-GENERATION FIBROSCAN® NOW AVAILABLE WORLDWIDE

HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024

AMRA Medical's Personalized Fat Z-scores (Photo: Business Wire)

AMRA Medical’s Innovative Fat Z-Score Biomarkers Show Tirzepatide Treatment is Associated with a Potential Targeted Effect on Visceral Fat and Liver Fat